Habitrol Patch, Extended Release
Product Images NDC 55741-448

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Habitrol (NDC 55741-448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

14mg 7ct

14mg 7ct
Habitrol Step 2 Nicotine Transdermal System Patch delivers 14 mg of nicotine over 24 hours as a stop smoking aid. The packaging indicates a 7-patch (1 week) kit including a behavior support program with self-help guide. Manufactured by Dr. Reddy's Laboratories Inc., it is intended for smokers reducing cigarette use as part of a step-down cessation process.*
FDA Label Image

21mg 7ct

21mg 7ct
Packaging label for Habitrol Step 2 Nicotine Transdermal System Patch delivering 21 mg over 24 hours. The extended-release patch is a stop smoking aid and contains 7 patches in a 1-week kit. The label shows directions for use, warnings, and includes a behavior support program with a self-help guide. Distributed by Dr. Reddy's Laboratories Inc.*
FDA Label Image

7mg 7ct

7mg 7ct
Habitrol Step 3 Nicotine Transdermal System Patch 7 mg/24h extended release patch for smoking cessation. The package contains 7 patches (1 week kit) and includes a behavior support program with self-help guide. Distributed by Dr. Reddy's Laboratories Inc. The label provides usage instructions, drug facts, warnings, and child-resistant pouch information.*
FDA Label Image

Steps (Steps)

Steps (Steps)
An instructional graphic for Habitrol Step 2 Nicotine Transdermal System Patch. It shows a three-step dosing schedule over eight weeks: Step 1 uses one 21 mg patch daily in weeks 1-4, Step 2 uses one 14 mg patch daily in weeks 5-6, and Step 3 uses one 7 mg patch daily in weeks 7-8.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.